NuCana is a clinical-stage biopharmaceutical company focused on significantly improving survival outcomes for patients with cancer. We use our proprietary ProTide™ technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines.
Our highly experienced management team has a successful track record of building global, integrated biopharmaceutical companies and bringing life-saving oncology therapeutics to patients.
"Utilising our proprietary ProTide technology platform we are developing new medicines designed to overcome key cancer resistance mechanisms and improve the survival outcomes for patients."
NuCana to Participate in the Piper Jaffray 31st Annual Healthcare Conference
Tuesday, Dec 3, 2019
3 Lochside Way
Edinburgh
EH12 9DT
United Kingdom
Telephone: +44 (0)131 357 1111
E-mail: info@nucana.com
275 Grove Street
Newton, MA 02466
Telephone: +1 617 663 4821
E-mail:info@nucana.com